Myriad Genetics Announces Second Quarter Fiscal 2007 Financial Results Conference Call

Tuesday, February 6, 2007 at 10:00 a.m. ET

SALT LAKE CITY--(BUSINESS WIRE)--Jan. 23, 2007--Myriad Genetics, Inc. (NASDAQ:MYGN) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc. and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

                        DATE: February 6, 2007
                          TIME: 10:00 am ET
                   DOMESTIC DIAL-IN: (888) 589-2820
                INTERNATIONAL DIAL-IN: (706) 634-2173
                        CONFERENCE ID# 6647309

(Please dial in approximately 10 minutes before the call is scheduled
                               to begin)

  A press release will be issued at 6:30 am ET on February 6, 2007.
 Replay of the call will be available from two hours after the call
  through February 13th by dialing (800) 642-1687 or (706) 645-9291,
              and entering conference ID number 6647309.

      A live audio Webcast will be available at: www.myriad.com

This call is being webcast by Thomson/CCBN and is also being distributed though the Thomson/StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com, Thomson/CCBN's individual investor portal. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

    CONTACT: Myriad Genetics
             Suzanne Barton, 801-584-1138

    SOURCE: Myriad Genetics, Inc.